Allos Therapeutics, Inc. (NASDAQ:ALTH)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer.

Recs

0
Player Avatar spundun (87.20) Submitted: 10/6/2009 8:42:47 PM : Outperform Start Price: $7.18 ALTH Score: -101.15

portefeuille, all stars.

Featured Broker Partners


Advertisement